Fahn S
J Clin Psychiatry. 1985 Apr;46(4 Pt 2):19-24.
An approach to treating tardive dyskinesia and tardive akathisia was tested in 33 patients. The common denominator was the elimination of antipsychotic drugs. In 7 of 8 patients with mild tardive dyskinesia and no akathisia who were treated by drug abstinence, gradual lessening of tardive dyskinesia occurred. Complete remission was seen after 2-4 years in 5 of these 8. Treatment with reserpine and discontinuance of antipsychotic drugs was useful for patients with severe symptoms of tardive dyskinesia or akathisia; complete remission with elimination of all drugs was achieved in 4 of 19 treated patients, without recurrence of symptoms. Although tetrabenazine masked symptoms in 5 of 7 patients to whom it was administered, none was able to achieve remission of tardive dyskinesia when taken off the drug. Seven of the total 33 patients received a course of levodopa; 2 of these 7 developed recurrence of their underlying psychosis. This agent should be used with caution.
在33例患者中测试了一种治疗迟发性运动障碍和迟发性静坐不能的方法。共同特点是停用抗精神病药物。在8例轻度迟发性运动障碍且无静坐不能的患者中,有7例通过停药治疗,迟发性运动障碍逐渐减轻。这8例中有5例在2至4年后完全缓解。对于有严重迟发性运动障碍或静坐不能症状的患者,使用利血平治疗并停用抗精神病药物是有效的;19例接受治疗的患者中有4例在停用所有药物后完全缓解,且症状未复发。尽管丁苯那嗪在7例服用该药的患者中有5例掩盖了症状,但停药后无一例能够使迟发性运动障碍缓解。33例患者中有7例接受了左旋多巴疗程治疗;这7例中有2例出现了潜在精神病的复发。使用该药物时应谨慎。